Welcome to the Dialogue on Nanotechnology in Cancer
The National Cancer Institute's Alliance for Nanotechnology in Cancer was launched in 2004 on the premise that nanotechnology based materials and devices have the potential to transform cancer research and clinical oncology. These materials and devices are leading to new solutions in early detection, in vivo imaging, and therapeutics for effective cancer treatment. The Alliance has achieved ongoing success and research progress in the forms of clinical trials, impactful publications and commercialization.
The NCI Office of Cancer Nanotechnology Research (OCNR) is charged with sculpting the future NCI investment plan in the field of cancer nanotechnology. Using this site, we solicited the public’s opinion on the relevant areas of focus and the most important research questions that need to be addressed in this field. We invited you to share your thoughts and comments with us using this forum.
Illustrated in the video below is a local community event organized by the David H. Koch Institute for Integrative Cancer Research at MIT that demonstrates the purpose of cutting-edge cancer nanotechnology research.
UPDATE ON THE RESULTS OF THIS EFFORT: During the three months we were actively seeking input on the website, March to May 2013, we had over 1,300 unique visits to the site. The visits came from 82 countries, including India, the United Kingdom, Spain, and Canada. The most frequent country represented was the USA, with 65% of the visitors.
The user and idea statistics can be found below. The topics discussed included Targeting, Drug Delivery, Metastasis and Circulating Tumor Cells, Nanoinformatics and several others. These ideas were presented at a Strategic Workshop on Cancer Nanotechnology organized by OCNR in June 2013 and were considered in the development of Funding Opportunity Announcements for the next phase of the Alliance for Nanotechnology in Cancer. The next phase of the program will be composed of Centers of Cancer Nanotechnology Research (U54; RFA-CA-14-013), Innovative Research in Cancer Nanotechnology (U01; PAR-14-285), and Cancer Nanotechnology Research Training Program (T32; PA-14-015) awards. Opening and receipt dates for each award type can be found in the associated announcements by clicking on the hyperlinked text, with awards to begin in September 2015.
As a next step for the Dialogue website, we have been soliciting educational videos from the Alliance and the wider cancer nanotechnology community to post on the site. Some videos are meant to educate the research community and general public, while others are meant to share information about innovations and resources available to the field. Currently, videos from the David H. Koch Institute for Integrative Cancer Research at MIT, Northwestern University, University of Kentucky, Case Western Reserve University, and the Nanotechnology Characterization Laboratory are posted here. New videos will be posted as we receive them, as well an announcements for upcoming opportunities to refine existing ideas and post new ones.
LOGISTICAL DETAILS CONCERNING YOUR INPUTS: To participate in this forum, click Register or Log In in the top right corner. You must become a registered user before you can submit, comment, or vote on ideas.
Ideas and comments submitted to the site are public. Your participation in this dialogue is voluntary, and no payments or gifts will be made to respondents. However, your participation will help to ensure that your expectations and priorities are considered. If you would like to volunteer information about your area of expertise and position level, please add this information to your profile. We will not make this information public. We are interested in knowing the makeup of our forum users. If you prefer not to create an account, you can submit your ideas or comments via e-mail to email@example.com.